Global Cholera Vaccines Oral Live Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 100

Published Date: 25 Jun 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Click To Send

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Cholera Vaccines Oral Live market size was valued at US$ 105 million in 2024 and is forecast to a readjusted size of USD 166 million by 2031 with a CAGR of 6.9% during review period. 
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.

Cholera Vaccines Oral Live

According to our (Global Info Research) latest study, the global Cholera Vaccines Oral Live market size was valued at US$ 105 million in 2024 and is forecast to a readjusted size of USD 166 million by 2031 with a CAGR of 6.9% during review period.

Unit: US$ M

www.globalinforesearch.com

Business Risk & Industry Analysis Reports

Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.

Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.

This report is a detailed and comprehensive analysis for global Cholera Vaccines Oral Live market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Cholera Vaccines Oral Live market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cholera Vaccines Oral Live market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cholera Vaccines Oral Live market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cholera Vaccines Oral Live market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cholera Vaccines Oral Live
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cholera Vaccines Oral Live market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PaxVax, Sanofi, Valneva, EuBiologics, Shanghai United Cell Biotechnology, Vabiotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Cholera Vaccines Oral Live market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Euvichol- Plus
    DUKORAL
    Shanchol
    Others

Market segment by Application
    Prevention
    Emergency Response

Major players covered
    PaxVax
    Sanofi
    Valneva
    EuBiologics
    Shanghai United Cell Biotechnology
    Vabiotech

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cholera Vaccines Oral Live product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cholera Vaccines Oral Live, with price, sales quantity, revenue, and global market share of Cholera Vaccines Oral Live from 2020 to 2025.
Chapter 3, the Cholera Vaccines Oral Live competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccines Oral Live breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cholera Vaccines Oral Live market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cholera Vaccines Oral Live.
Chapter 14 and 15, to describe Cholera Vaccines Oral Live sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Euvichol- Plus
        1.3.3 DUKORAL
        1.3.4 Shanchol
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Cholera Vaccines Oral Live Consumption Value by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Prevention
        1.4.3 Emergency Response
    1.5 Global Cholera Vaccines Oral Live Market Size & Forecast
        1.5.1 Global Cholera Vaccines Oral Live Consumption Value (2020 & 2024 & 2031)
        1.5.2 Global Cholera Vaccines Oral Live Sales Quantity (2020-2031)
        1.5.3 Global Cholera Vaccines Oral Live Average Price (2020-2031)

2 Manufacturers Profiles
    2.1 PaxVax
        2.1.1 PaxVax Details
        2.1.2 PaxVax Major Business
        2.1.3 PaxVax Cholera Vaccines Oral Live Product and Services
        2.1.4 PaxVax Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 PaxVax Recent Developments/Updates
    2.2 Sanofi
        2.2.1 Sanofi Details
        2.2.2 Sanofi Major Business
        2.2.3 Sanofi Cholera Vaccines Oral Live Product and Services
        2.2.4 Sanofi Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Sanofi Recent Developments/Updates
    2.3 Valneva
        2.3.1 Valneva Details
        2.3.2 Valneva Major Business
        2.3.3 Valneva Cholera Vaccines Oral Live Product and Services
        2.3.4 Valneva Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Valneva Recent Developments/Updates
    2.4 EuBiologics
        2.4.1 EuBiologics Details
        2.4.2 EuBiologics Major Business
        2.4.3 EuBiologics Cholera Vaccines Oral Live Product and Services
        2.4.4 EuBiologics Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 EuBiologics Recent Developments/Updates
    2.5 Shanghai United Cell Biotechnology
        2.5.1 Shanghai United Cell Biotechnology Details
        2.5.2 Shanghai United Cell Biotechnology Major Business
        2.5.3 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
        2.5.4 Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
    2.6 Vabiotech
        2.6.1 Vabiotech Details
        2.6.2 Vabiotech Major Business
        2.6.3 Vabiotech Cholera Vaccines Oral Live Product and Services
        2.6.4 Vabiotech Cholera Vaccines Oral Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Vabiotech Recent Developments/Updates

3 Competitive Environment: Cholera Vaccines Oral Live by Manufacturer
    3.1 Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2020-2025)
    3.2 Global Cholera Vaccines Oral Live Revenue by Manufacturer (2020-2025)
    3.3 Global Cholera Vaccines Oral Live Average Price by Manufacturer (2020-2025)
    3.4 Market Share Analysis (2024)
        3.4.1 Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Revenue ($MM) and Market Share (%): 2024
        3.4.2 Top 3 Cholera Vaccines Oral Live Manufacturer Market Share in 2024
        3.4.3 Top 6 Cholera Vaccines Oral Live Manufacturer Market Share in 2024
    3.5 Cholera Vaccines Oral Live Market: Overall Company Footprint Analysis
        3.5.1 Cholera Vaccines Oral Live Market: Region Footprint
        3.5.2 Cholera Vaccines Oral Live Market: Company Product Type Footprint
        3.5.3 Cholera Vaccines Oral Live Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Cholera Vaccines Oral Live Market Size by Region
        4.1.1 Global Cholera Vaccines Oral Live Sales Quantity by Region (2020-2031)
        4.1.2 Global Cholera Vaccines Oral Live Consumption Value by Region (2020-2031)
        4.1.3 Global Cholera Vaccines Oral Live Average Price by Region (2020-2031)
    4.2 North America Cholera Vaccines Oral Live Consumption Value (2020-2031)
    4.3 Europe Cholera Vaccines Oral Live Consumption Value (2020-2031)
    4.4 Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2020-2031)
    4.5 South America Cholera Vaccines Oral Live Consumption Value (2020-2031)
    4.6 Middle East & Africa Cholera Vaccines Oral Live Consumption Value (2020-2031)

5 Market Segment by Type
    5.1 Global Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    5.2 Global Cholera Vaccines Oral Live Consumption Value by Type (2020-2031)
    5.3 Global Cholera Vaccines Oral Live Average Price by Type (2020-2031)

6 Market Segment by Application
    6.1 Global Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    6.2 Global Cholera Vaccines Oral Live Consumption Value by Application (2020-2031)
    6.3 Global Cholera Vaccines Oral Live Average Price by Application (2020-2031)

7 North America
    7.1 North America Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    7.2 North America Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    7.3 North America Cholera Vaccines Oral Live Market Size by Country
        7.3.1 North America Cholera Vaccines Oral Live Sales Quantity by Country (2020-2031)
        7.3.2 North America Cholera Vaccines Oral Live Consumption Value by Country (2020-2031)
        7.3.3 United States Market Size and Forecast (2020-2031)
        7.3.4 Canada Market Size and Forecast (2020-2031)
        7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
    8.1 Europe Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    8.2 Europe Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    8.3 Europe Cholera Vaccines Oral Live Market Size by Country
        8.3.1 Europe Cholera Vaccines Oral Live Sales Quantity by Country (2020-2031)
        8.3.2 Europe Cholera Vaccines Oral Live Consumption Value by Country (2020-2031)
        8.3.3 Germany Market Size and Forecast (2020-2031)
        8.3.4 France Market Size and Forecast (2020-2031)
        8.3.5 United Kingdom Market Size and Forecast (2020-2031)
        8.3.6 Russia Market Size and Forecast (2020-2031)
        8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
    9.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    9.2 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    9.3 Asia-Pacific Cholera Vaccines Oral Live Market Size by Region
        9.3.1 Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2020-2031)
        9.3.2 Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2020-2031)
        9.3.3 China Market Size and Forecast (2020-2031)
        9.3.4 Japan Market Size and Forecast (2020-2031)
        9.3.5 South Korea Market Size and Forecast (2020-2031)
        9.3.6 India Market Size and Forecast (2020-2031)
        9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
        9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
    10.1 South America Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    10.2 South America Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    10.3 South America Cholera Vaccines Oral Live Market Size by Country
        10.3.1 South America Cholera Vaccines Oral Live Sales Quantity by Country (2020-2031)
        10.3.2 South America Cholera Vaccines Oral Live Consumption Value by Country (2020-2031)
        10.3.3 Brazil Market Size and Forecast (2020-2031)
        10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
    11.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2020-2031)
    11.2 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2020-2031)
    11.3 Middle East & Africa Cholera Vaccines Oral Live Market Size by Country
        11.3.1 Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Country (2020-2031)
        11.3.2 Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Country (2020-2031)
        11.3.3 Turkey Market Size and Forecast (2020-2031)
        11.3.4 Egypt Market Size and Forecast (2020-2031)
        11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
        11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
    12.1 Cholera Vaccines Oral Live Market Drivers
    12.2 Cholera Vaccines Oral Live Market Restraints
    12.3 Cholera Vaccines Oral Live Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Cholera Vaccines Oral Live and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Cholera Vaccines Oral Live
    13.3 Cholera Vaccines Oral Live Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Cholera Vaccines Oral Live Typical Distributors
    14.3 Cholera Vaccines Oral Live Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cholera Vaccines Oral Live Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
 Table 4. PaxVax Major Business
 Table 5. PaxVax Cholera Vaccines Oral Live Product and Services
 Table 6. PaxVax Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 7. PaxVax Recent Developments/Updates
 Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 9. Sanofi Major Business
 Table 10. Sanofi Cholera Vaccines Oral Live Product and Services
 Table 11. Sanofi Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 12. Sanofi Recent Developments/Updates
 Table 13. Valneva Basic Information, Manufacturing Base and Competitors
 Table 14. Valneva Major Business
 Table 15. Valneva Cholera Vaccines Oral Live Product and Services
 Table 16. Valneva Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 17. Valneva Recent Developments/Updates
 Table 18. EuBiologics Basic Information, Manufacturing Base and Competitors
 Table 19. EuBiologics Major Business
 Table 20. EuBiologics Cholera Vaccines Oral Live Product and Services
 Table 21. EuBiologics Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 22. EuBiologics Recent Developments/Updates
 Table 23. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
 Table 24. Shanghai United Cell Biotechnology Major Business
 Table 25. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Product and Services
 Table 26. Shanghai United Cell Biotechnology Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 27. Shanghai United Cell Biotechnology Recent Developments/Updates
 Table 28. Vabiotech Basic Information, Manufacturing Base and Competitors
 Table 29. Vabiotech Major Business
 Table 30. Vabiotech Cholera Vaccines Oral Live Product and Services
 Table 31. Vabiotech Cholera Vaccines Oral Live Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 32. Vabiotech Recent Developments/Updates
 Table 33. Global Cholera Vaccines Oral Live Sales Quantity by Manufacturer (2020-2025) & (K Units)
 Table 34. Global Cholera Vaccines Oral Live Revenue by Manufacturer (2020-2025) & (USD Million)
 Table 35. Global Cholera Vaccines Oral Live Average Price by Manufacturer (2020-2025) & (USD/Unit)
 Table 36. Market Position of Manufacturers in Cholera Vaccines Oral Live, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 37. Head Office and Cholera Vaccines Oral Live Production Site of Key Manufacturer
 Table 38. Cholera Vaccines Oral Live Market: Company Product Type Footprint
 Table 39. Cholera Vaccines Oral Live Market: Company Product Application Footprint
 Table 40. Cholera Vaccines Oral Live New Market Entrants and Barriers to Market Entry
 Table 41. Cholera Vaccines Oral Live Mergers, Acquisition, Agreements, and Collaborations
 Table 42. Global Cholera Vaccines Oral Live Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
 Table 43. Global Cholera Vaccines Oral Live Sales Quantity by Region (2020-2025) & (K Units)
 Table 44. Global Cholera Vaccines Oral Live Sales Quantity by Region (2026-2031) & (K Units)
 Table 45. Global Cholera Vaccines Oral Live Consumption Value by Region (2020-2025) & (USD Million)
 Table 46. Global Cholera Vaccines Oral Live Consumption Value by Region (2026-2031) & (USD Million)
 Table 47. Global Cholera Vaccines Oral Live Average Price by Region (2020-2025) & (USD/Unit)
 Table 48. Global Cholera Vaccines Oral Live Average Price by Region (2026-2031) & (USD/Unit)
 Table 49. Global Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 50. Global Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 51. Global Cholera Vaccines Oral Live Consumption Value by Type (2020-2025) & (USD Million)
 Table 52. Global Cholera Vaccines Oral Live Consumption Value by Type (2026-2031) & (USD Million)
 Table 53. Global Cholera Vaccines Oral Live Average Price by Type (2020-2025) & (USD/Unit)
 Table 54. Global Cholera Vaccines Oral Live Average Price by Type (2026-2031) & (USD/Unit)
 Table 55. Global Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 56. Global Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 57. Global Cholera Vaccines Oral Live Consumption Value by Application (2020-2025) & (USD Million)
 Table 58. Global Cholera Vaccines Oral Live Consumption Value by Application (2026-2031) & (USD Million)
 Table 59. Global Cholera Vaccines Oral Live Average Price by Application (2020-2025) & (USD/Unit)
 Table 60. Global Cholera Vaccines Oral Live Average Price by Application (2026-2031) & (USD/Unit)
 Table 61. North America Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 62. North America Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 63. North America Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 64. North America Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 65. North America Cholera Vaccines Oral Live Sales Quantity by Country (2020-2025) & (K Units)
 Table 66. North America Cholera Vaccines Oral Live Sales Quantity by Country (2026-2031) & (K Units)
 Table 67. North America Cholera Vaccines Oral Live Consumption Value by Country (2020-2025) & (USD Million)
 Table 68. North America Cholera Vaccines Oral Live Consumption Value by Country (2026-2031) & (USD Million)
 Table 69. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 70. Europe Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 71. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 72. Europe Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 73. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2020-2025) & (K Units)
 Table 74. Europe Cholera Vaccines Oral Live Sales Quantity by Country (2026-2031) & (K Units)
 Table 75. Europe Cholera Vaccines Oral Live Consumption Value by Country (2020-2025) & (USD Million)
 Table 76. Europe Cholera Vaccines Oral Live Consumption Value by Country (2026-2031) & (USD Million)
 Table 77. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 78. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 79. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 80. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 81. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2020-2025) & (K Units)
 Table 82. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity by Region (2026-2031) & (K Units)
 Table 83. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2020-2025) & (USD Million)
 Table 84. Asia-Pacific Cholera Vaccines Oral Live Consumption Value by Region (2026-2031) & (USD Million)
 Table 85. South America Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 86. South America Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 87. South America Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 88. South America Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 89. South America Cholera Vaccines Oral Live Sales Quantity by Country (2020-2025) & (K Units)
 Table 90. South America Cholera Vaccines Oral Live Sales Quantity by Country (2026-2031) & (K Units)
 Table 91. South America Cholera Vaccines Oral Live Consumption Value by Country (2020-2025) & (USD Million)
 Table 92. South America Cholera Vaccines Oral Live Consumption Value by Country (2026-2031) & (USD Million)
 Table 93. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2020-2025) & (K Units)
 Table 94. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Type (2026-2031) & (K Units)
 Table 95. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2020-2025) & (K Units)
 Table 96. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Application (2026-2031) & (K Units)
 Table 97. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Country (2020-2025) & (K Units)
 Table 98. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity by Country (2026-2031) & (K Units)
 Table 99. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Country (2020-2025) & (USD Million)
 Table 100. Middle East & Africa Cholera Vaccines Oral Live Consumption Value by Country (2026-2031) & (USD Million)
 Table 101. Cholera Vaccines Oral Live Raw Material
 Table 102. Key Manufacturers of Cholera Vaccines Oral Live Raw Materials
 Table 103. Cholera Vaccines Oral Live Typical Distributors
 Table 104. Cholera Vaccines Oral Live Typical Customers


List of Figures
 Figure 1. Cholera Vaccines Oral Live Picture
 Figure 2. Global Cholera Vaccines Oral Live Revenue by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Cholera Vaccines Oral Live Revenue Market Share by Type in 2024
 Figure 4. Euvichol- Plus Examples
 Figure 5. DUKORAL Examples
 Figure 6. Shanchol Examples
 Figure 7. Others Examples
 Figure 8. Global Cholera Vaccines Oral Live Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 9. Global Cholera Vaccines Oral Live Revenue Market Share by Application in 2024
 Figure 10. Prevention Examples
 Figure 11. Emergency Response Examples
 Figure 12. Global Cholera Vaccines Oral Live Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 13. Global Cholera Vaccines Oral Live Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 14. Global Cholera Vaccines Oral Live Sales Quantity (2020-2031) & (K Units)
 Figure 15. Global Cholera Vaccines Oral Live Price (2020-2031) & (USD/Unit)
 Figure 16. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Manufacturer in 2024
 Figure 17. Global Cholera Vaccines Oral Live Revenue Market Share by Manufacturer in 2024
 Figure 18. Producer Shipments of Cholera Vaccines Oral Live by Manufacturer Sales ($MM) and Market Share (%): 2024
 Figure 19. Top 3 Cholera Vaccines Oral Live Manufacturer (Revenue) Market Share in 2024
 Figure 20. Top 6 Cholera Vaccines Oral Live Manufacturer (Revenue) Market Share in 2024
 Figure 21. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2020-2031)
 Figure 22. Global Cholera Vaccines Oral Live Consumption Value Market Share by Region (2020-2031)
 Figure 23. North America Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 24. Europe Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 25. Asia-Pacific Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 26. South America Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 27. Middle East & Africa Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 28. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 29. Global Cholera Vaccines Oral Live Consumption Value Market Share by Type (2020-2031)
 Figure 30. Global Cholera Vaccines Oral Live Average Price by Type (2020-2031) & (USD/Unit)
 Figure 31. Global Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 32. Global Cholera Vaccines Oral Live Revenue Market Share by Application (2020-2031)
 Figure 33. Global Cholera Vaccines Oral Live Average Price by Application (2020-2031) & (USD/Unit)
 Figure 34. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 35. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 36. North America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2020-2031)
 Figure 37. North America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2020-2031)
 Figure 38. United States Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 39. Canada Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 40. Mexico Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 41. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 42. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 43. Europe Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2020-2031)
 Figure 44. Europe Cholera Vaccines Oral Live Consumption Value Market Share by Country (2020-2031)
 Figure 45. Germany Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 46. France Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 47. United Kingdom Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 48. Russia Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 49. Italy Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 50. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 51. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 52. Asia-Pacific Cholera Vaccines Oral Live Sales Quantity Market Share by Region (2020-2031)
 Figure 53. Asia-Pacific Cholera Vaccines Oral Live Consumption Value Market Share by Region (2020-2031)
 Figure 54. China Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 55. Japan Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 56. South Korea Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 57. India Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 58. Southeast Asia Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 59. Australia Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 60. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 61. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 62. South America Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2020-2031)
 Figure 63. South America Cholera Vaccines Oral Live Consumption Value Market Share by Country (2020-2031)
 Figure 64. Brazil Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 65. Argentina Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 66. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Type (2020-2031)
 Figure 67. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Application (2020-2031)
 Figure 68. Middle East & Africa Cholera Vaccines Oral Live Sales Quantity Market Share by Country (2020-2031)
 Figure 69. Middle East & Africa Cholera Vaccines Oral Live Consumption Value Market Share by Country (2020-2031)
 Figure 70. Turkey Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 71. Egypt Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 72. Saudi Arabia Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 73. South Africa Cholera Vaccines Oral Live Consumption Value (2020-2031) & (USD Million)
 Figure 74. Cholera Vaccines Oral Live Market Drivers
 Figure 75. Cholera Vaccines Oral Live Market Restraints
 Figure 76. Cholera Vaccines Oral Live Market Trends
 Figure 77. Porters Five Forces Analysis
 Figure 78. Manufacturing Cost Structure Analysis of Cholera Vaccines Oral Live in 2024
 Figure 79. Manufacturing Process Analysis of Cholera Vaccines Oral Live
 Figure 80. Cholera Vaccines Oral Live Industrial Chain
 Figure 81. Sales Channel: Direct to End-User vs Distributors
 Figure 82. Direct Channel Pros & Cons
 Figure 83. Indirect Channel Pros & Cons
 Figure 84. Methodology
 Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech

Related Reports

Global Cholera Vaccines Oral Live Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Cholera Vaccines Oral Live Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 2 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cholera Vaccines Oral Live market size was valued at USD 87 million in 2023 and is forecast to a readjusted size of USD 137.6 million by 2030 with a CAGR of 6.7% during review period.

Product Tags

Cholera Vaccines Oral Live

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi Users License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords
artificial intelligence
electron
semiconductor
Battery
5G
new energy
AI
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.
Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.
Contact Us >>